IL138477A0 - Cyclic aminoguanidines - Google Patents

Cyclic aminoguanidines

Info

Publication number
IL138477A0
IL138477A0 IL13847799A IL13847799A IL138477A0 IL 138477 A0 IL138477 A0 IL 138477A0 IL 13847799 A IL13847799 A IL 13847799A IL 13847799 A IL13847799 A IL 13847799A IL 138477 A0 IL138477 A0 IL 138477A0
Authority
IL
Israel
Prior art keywords
aminoguanidines
cyclic
cyclic aminoguanidines
Prior art date
Application number
IL13847799A
Other languages
English (en)
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of IL138477A0 publication Critical patent/IL138477A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
IL13847799A 1998-03-23 1999-03-19 Cyclic aminoguanidines IL138477A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0051598A AT406772B (de) 1998-03-23 1998-03-23 Antibakterielle 7-acylamino-3-iminomethyl- cephalosporine und verfahren zu deren herstellung
PCT/EP1999/001853 WO1999048896A1 (en) 1998-03-23 1999-03-19 Cephalosporines having cyclic aminoguanidine substituents as antibiotics

Publications (1)

Publication Number Publication Date
IL138477A0 true IL138477A0 (en) 2001-10-31

Family

ID=3492649

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13847799A IL138477A0 (en) 1998-03-23 1999-03-19 Cyclic aminoguanidines
IL138477A IL138477A (en) 1998-03-23 2000-09-14 7 - acylamino - 3 - (cyclic aminoguanidines) methylene cephalosporins, their preparation and pharmaceutical compositions comprising them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL138477A IL138477A (en) 1998-03-23 2000-09-14 7 - acylamino - 3 - (cyclic aminoguanidines) methylene cephalosporins, their preparation and pharmaceutical compositions comprising them

Country Status (25)

Country Link
US (1) US6440957B1 (cg-RX-API-DMAC10.html)
EP (2) EP1930335A1 (cg-RX-API-DMAC10.html)
JP (1) JP2002507616A (cg-RX-API-DMAC10.html)
KR (1) KR100696422B1 (cg-RX-API-DMAC10.html)
CN (1) CN1188418C (cg-RX-API-DMAC10.html)
AR (1) AR015248A1 (cg-RX-API-DMAC10.html)
AT (1) AT406772B (cg-RX-API-DMAC10.html)
AU (1) AU749735B2 (cg-RX-API-DMAC10.html)
BR (1) BR9908960A (cg-RX-API-DMAC10.html)
CA (1) CA2324953C (cg-RX-API-DMAC10.html)
CO (1) CO5080739A1 (cg-RX-API-DMAC10.html)
HU (1) HUP0101603A3 (cg-RX-API-DMAC10.html)
ID (1) ID26567A (cg-RX-API-DMAC10.html)
IL (2) IL138477A0 (cg-RX-API-DMAC10.html)
MY (1) MY119841A (cg-RX-API-DMAC10.html)
NO (1) NO20004760L (cg-RX-API-DMAC10.html)
NZ (1) NZ506908A (cg-RX-API-DMAC10.html)
PE (1) PE20000360A1 (cg-RX-API-DMAC10.html)
PL (1) PL343094A1 (cg-RX-API-DMAC10.html)
RU (1) RU2245884C2 (cg-RX-API-DMAC10.html)
SK (1) SK14152000A3 (cg-RX-API-DMAC10.html)
TR (1) TR200002749T2 (cg-RX-API-DMAC10.html)
TW (1) TWI250983B (cg-RX-API-DMAC10.html)
WO (1) WO1999048896A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200004850B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693095B2 (en) * 1997-04-01 2004-02-17 Biochemie Gesellschaft M.B.H. Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
DE102007052891A1 (de) 2007-11-02 2009-05-07 Evonik Degussa Gmbh Verfahren zur Stabilisierung von olefinisch ungesättigten Monomeren
DE102013204950A1 (de) 2013-03-20 2014-09-25 Evonik Industries Ag Verfahren und Zusammensetzung zur Inhibierung der Polymerisation von Cyclopentadienverbindungen
ES2624415T3 (es) 2014-09-08 2017-07-14 Evonik Degussa Gmbh (Tio)acetales fenólicos como agentes inhibidores de la polimerización de monómeros olefínicamente insaturados
TWI669317B (zh) 2014-09-22 2019-08-21 德商贏創德固賽有限責任公司 反應性單體的改良製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE943408C (de) * 1953-03-31 1956-05-17 Bayer Ag Verfahren zur Darstellung von Bisguanylhydrazonen
FI851934L (fi) * 1984-05-30 1985-12-01 Ici Plc Kefalosporinderivat.
GB8721568D0 (en) * 1987-09-14 1987-10-21 Fujisawa Pharmaceutical Co Cephem compounds
ATE233268T1 (de) * 1995-05-11 2003-03-15 Biochemie Gmbh Antibakterielle cephalosporinverbindungen
BR9807913A (pt) * 1997-04-01 2000-02-22 Biochemie Gmbh 7-acilamino-3-(metilhidrazono)metil cefalosporinas substituìdas antibacterianas e intermediários

Also Published As

Publication number Publication date
HUP0101603A3 (en) 2002-10-28
NO20004760D0 (no) 2000-09-22
NZ506908A (en) 2003-04-29
TWI250983B (en) 2006-03-11
PL343094A1 (en) 2001-07-30
ATA51598A (de) 2000-01-15
AU3518899A (en) 1999-10-18
BR9908960A (pt) 2000-12-05
IL138477A (en) 2007-06-17
WO1999048896A1 (en) 1999-09-30
AR015248A1 (es) 2001-04-18
AT406772B (de) 2000-08-25
CN1294593A (zh) 2001-05-09
MY119841A (en) 2005-07-29
KR100696422B1 (ko) 2007-03-20
NO20004760L (no) 2000-11-21
HUP0101603A2 (hu) 2001-12-28
EP1930335A1 (en) 2008-06-11
US6440957B1 (en) 2002-08-27
CO5080739A1 (es) 2001-09-25
SK14152000A3 (sk) 2001-05-10
ID26567A (id) 2001-01-18
JP2002507616A (ja) 2002-03-12
AU749735B2 (en) 2002-07-04
RU2245884C2 (ru) 2005-02-10
TR200002749T2 (tr) 2000-12-21
EP1082326A1 (en) 2001-03-14
PE20000360A1 (es) 2000-05-17
KR20010074666A (ko) 2001-08-08
ZA200004850B (en) 2002-02-27
CA2324953C (en) 2008-05-13
CA2324953A1 (en) 1999-09-30
CN1188418C (zh) 2005-02-09

Similar Documents

Publication Publication Date Title
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE59912303D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE69904335D1 (en) Aminomethylcarbonsäurederivate
DE69914921D1 (en) Phenyl-xanthinderivate
AU136536S (en) Case
DE59903023D1 (en) Perorale wirkstoff-suspension
DE69908871D1 (en) Thermisch härtbare glasplatte
DE59914151D1 (en) Arylalkanoylpyridazine
DE60042897D1 (en) Photovervielfacherröhre
DE69905001D1 (en) Koagulationsvorrichtung
DE69904442D1 (en) Cyclohexandiol-derivate
DE59904407D1 (en) Chromanderivate
TW395202U (en) Carrying case
EP1083910A4 (en) nrdE
DE69821502D1 (en) Boroskop
DE59900495D1 (en) Multimetalloxidmassen
GB9808496D0 (en) Resistance-monitoring arrangement
HUP0105165A3 (en) Lichting arrangement
HU9900892D0 (en) Enclosed multiple-biofilter
GB9814620D0 (en) Vasculoprotector
HUP0102261A3 (en) Coffee-grinder
DE59900471D1 (en) Inchbremseinrichtung
DE69912430D1 (en) Hydroformylierungsreaktionen
GB2335259B (en) An explosion-suppressing structure

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees